Abivax

ABVXNasdaq France Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.906 B

$103.45 -1.51%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

78,536,412

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#36CytokineticsCYTK$9.39B
#37Protagonist TherapeuticsPTGX$9.38B
#38AbivaxABVX$8.91B
#39Tg TherapeuticsTGTX$8.75B
#40Praxis Precision MedicinesPRAX$8.34B

What if Abivax were worth as much as…

Open the what-if tool →

Gold $30.3T

$351,637.35

Per share 3,399× higher

Bitcoin $1.72T

$19,975.76

Per share 193× higher

Nvidia $5.48T

$63,649.31

Per share 615× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Abivax are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.